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Background: Cancer-related fatigue (CRF) is the most common and distressing symptom in breast cancer survivors.
Approximately 40% to 80% of cancer patients undergoing active treatment suffer from CRF. Exercise improves
overall quality of life and CRF; however, the specific effects of the training modalities are not well understood.
Methods: This study aimed to determine the pooled effects of supervised exercise interventions on CRF in breast
cancer survivors. We searched PubMed/MEDLINE, EMBASE, Scopus, CENTRAL and CINAHL databases between
December 2013 and January 2014 without language restrictions. Risk of bias and methodological quality were
evaluated using the PEDro score. Pooled effects were calculated with a random-effects model according to the
DerSimonian and Laird method. Heterogeneity was evaluated with the I2 test.
Results: Nine high-quality studies (n = 1156) were finally included. Supervised aerobic exercise was statistically more
effective than conventional care in improving CRF among breast cancer survivors (SMD = −0.51, 95%CI −0.81 to −0.21),
with high statistical heterogeneity (P = 0.001; I2 = 75%). Similar effects were found for resistance training on CRF
(SMD = −0.41, 95%CI −0.76 to −0.05; P = 0.02; I2 = 64%). Meta-regression analysis revealed that exercise volume
parameters are closely related with the effect estimates on CRF. Egger’s test suggested moderate evidence of
publication bias (P = 0.04).
Conclusions: Supervised exercise reduces CRF and must be implemented in breast cancer rehabilitation settings.
High-volume exercises are safe and effective in improving CRF and overall quality of life in women with breast
cancer. Further research is encouraged.
Trial Registration: CRD42014007223
Keywords: Breast Neoplasms, Exercise, Resistance training, Rehabilitation, Medical oncologyBackground
Breast cancer is the most common cancer in women
worldwide [1,2]. Breast cancer is also a leading cause of
cancer death among women, accounting for 23% of total
cancer cases and 14% of cancer deaths [3]. The World
Health Organization (WHO) [4] estimated that breast
cancer incidence in South America was 114,898 cases in
2008. In Colombia, nearly 5,000 new cases are diagnosed
annually [5]. However, due to significant improvements
in screening protocols, diagnosis, and treatment over the* Correspondence: menesesjose77@gmail.com
1Grupo GICAEDS. Facultad de Cultura Física, Deporte y Recreación,
Universidad Santo Tomás, Bogotá, D.C, Colombia
Full list of author information is available at the end of the article
© 2015 Meneses-Echávez et al.; licensee BioM
Creative Commons Attribution License (http:/
distribution, and reproduction in any medium
Domain Dedication waiver (http://creativecom
article, unless otherwise stated.past few decades, breast cancer mortality has progres-
sively decreased [6,7].
Cancer-related fatigue (CRF) is the most common and
devastating symptom in breast cancer patients during
and after therapeutic treatment [8]. Breast cancer patients
continue to experience fatigue symptoms for months or
years after successful treatment. Stone and colleagues
observed that 75% of patients with various solid tumors
(among whom 48 of 95 had metastatic disease) had a sig-
nificantly increased cancer-related fatigue score compared
with a matched control population [9]. It has been sug-
gested that CRF might be considered a strong predictor of
lower survival for cancer patients [10].ed Central. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/4.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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pharmacological therapy in cancer patients [11-13]. A
growing body of evidence supports the idea that increasing
physical activity provides important benefits to promote
psychological outcomes and physical well-being in cancer
patients [13-16]. These symptoms have been associated
with clinical-related outcomes in breast cancer patients re-
ceiving active treatment regimens [11,13,17-24]. Some sys-
tematic reviews have communicated ambiguous findings
concerning the effects of exercise interventions on CRF
[11-13,15-22]. A recent Cochrane systematic review about
exercise and CRF [17] concluded that aerobic exercise re-
duces CRF and encouraged further research of other exer-
cise modalities. However, that review only included data
published by March 2011 and did not examine supervised
physical activity interventions in isolation from unsuper-
vised interventions. A recent prospective randomized pilot
trial by Oechsle et al. [25] reported that supervised exercise
improved fatigue symptoms in 48 patients receiving mye-
loablative chemotherapy during the hospitalization period
for chemotherapy. Nonetheless, the optimal doses and
modes of exercise have not been addressed [26-28], yet
these issues are essential to reach a more complete under-
standing of CRF control through supervised exercise train-
ing. In light of these gaps in the literature, this systematic
review aimed to determine the pooled effects of supervised
exercise interventions on CRF in breast cancer survivors,
via a meta-analysis of randomized controlled trials.
Methods
Protocol and objective
This systematic review was conducted and reported in
accordance with the Preferred Reporting Items for Sys-
tematic Reviews and Meta-Analyses (PRISMA) Statement
[29] (PROSPERO Register code: CRD42014007223). No
funding support was received in this study.
Search methods
Two blinded authors (JFM-E and RR-V) independently
applied the search strategy between December 2013 and
January 2014. The electronic databases (PubMed/MED-
LINE, EMBASE, Scopus, CENTRAL and CINAHL)
databases were systematically searched by combining
Boolean operators and any of the following search terms:
“breast cancer”, “cancer-related fatigue” and “exercise”.
(See Appendix 1 for further details). The authors incorpo-
rated the recommendations of Robinson and Dickersin
[30] to achieve a highly sensitive search strategy for the re-
trieval of clinical trials on PubMed. The title and abstract
were examined and full text was obtained if there was
ambiguity regarding eligibility. In addition, the authors
examined the reference lists of the identified records
and the conference abstracts of the American Society
of Clinical Oncology (ASCO) Annual Meeting on itswebsite from 2004 to 2013, as well as certain journals
(i.e., The Lancet Oncology, Journal of Clinical Oncology,
Journal of the National Cancer Institute, Journal of Breast
Cancer, The Breast Journal, and The Breast). No language
restrictions were applied. Attempts were made to contact
authors of trial reports if clarification was necessary.
Ethics proclamations
This systematic review and meta-analysis included ex-
perimental studies that followed the provisions stated in
the Declaration of Helsinki and were approved by the
Ethics Committee. All patients signed informed consent.
One author (JFM-E) performed this verification.
Selection criteria
After screening the search results, two blinded authors
(JFM-E and EGJ) independently evaluated eligibility of
all studies retrieved from the databases based on the se-
lection criteria. The studies were included if they met
the following criteria according to the Patient/Problem,
Intervention, Comparison/Control or Comparator and
Outcomes/ Effects (PICO) methodology [29].
We included randomized controlled trials involving
breast cancer survivors without restrictions to a particu-
lar stage of disease. Systematic reviews, editorials, cross-
sectional studies, case reports and case series studies
were excluded. We performed a subgroup analysis
according to the stage of treatment for those studies
involving participants during or after therapeutic anti-
cancer treatment. Supervised exercise interventions were
included in the systematic review, while non-supervised
exercise programs were excluded. Exercise interventions
were evaluated according to the definition of physical
activity provided by Wolin et al. [31], “as any body
movement causing an increase in energy expenditure
that involves a planned or structured movement of the
body performed in a systematic manner in terms of fre-
quency, intensity, and duration and is designed to maintain
or enhance health-related outcomes”. Therefore, tai-chi,
manual therapy (joint mobilization techniques and thera-
peutic massage) and cognitive-behavioral interventions
were excluded due to excessive variation in their mode,
frequency, duration and intensity. Conventional care was
considered a comparison group, and this group included
women who did not participate in any exercise interven-
tion program. Studies that compared supervised exercise
with pharmacological and surgical treatments were ex-
cluded. Disagreements were resolved by consensus and the
participation of a third author (RRV).
Data extraction and quality assessment
Two authors (JFM-E and RRV) independently per-
formed data extraction. Relevant data were extracted to
a computer-based spreadsheet. The reviewers extracted
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tion year, study design, cancer treatment, time since
diagnosis and characteristics of the exercise interven-
tions (mode of training, length, duration and frequency)
and effect estimates.
The methodological quality of the studies, including
their risk of bias, was assessed using the PEDro scale,
which is based on the Delphi list [32]. The PEDro scale
scores the methodological quality of randomized trials
out of 10. The score for each included study was deter-
mined by a trained assessor (JFM-E). Scores were based
on all information available from both the published ver-
sion and from communication with the authors. A score
of 5 of 10 was set as the minimum score for inclusion in
the current meta-analysis [33]. Three authors (JFM-E,
RRV and EGJ) independently performed this assessment.
Outcome measures
Cancer-related fatigue (CRF) was the primary outcome
measure. The National Comprehensive Cancer Network
(NCCN) [34] defines CRF as “a distressing, persistent, sub-
jective sense of physical, emotional and/or cognitive tired-
ness or exhaustion related to cancer or cancer treatment
that is not proportional to recent activity and interferes
with usual functioning.” We considered the following vali-
dated tools for the measurement of fatigue levels: the
Functional Assessment of Cancer Therapy (FACT)-Fatigue
Scale, European Organization for Research and Treatment
of Cancer Quality of Life Questionnaire (EORTC QLQ-
C30), Piper Fatigue Scale (PFS), Schwartz Cancer Fatigue
Scale (SCFS) and the Multidimensional Fatigue Inventory
(MFI). Furthermore, we considered the following second-
ary outcome measures: depression; body mass index (BMI)
as an indicator of body composition closely related to can-
cer progression; physical activity levels (minutes per week);
and quality of life including physical, social, emotional and
functional well-being. Pooled analysis for secondary out-
comes was carried out if at least two studies were available
for the outcome.
Data synthesis
All statistical analyses were conducted using Compre-
hensive Meta-Analysis and Review Manager Software
[35], developed by the Cochrane Collaboration. CRF was
reported as continuous data. Therefore, we recorded
both the mean change from baseline for each group or
the mean post-intervention and standard deviation. Con-
sidering that different scales were used for the outcome
measurements, we calculated standardized mean differ-
ences (SMD) with 95% confidence intervals (CI). If
standard deviations were not reported, they were esti-
mated through standard errors (CI or t values) [36].
SMDs were significant if their 95% CIs excluded zero.
When high heterogeneity (I2 > 50%) was detected, thepooled effects were calculated by using a random-effects
model reported in accordance with the DerSimonian
and Laird method, which considers both within-study
and between-study differences [36]. On the contrary, if
substantial heterogeneity was not detected, we con-
ducted a fixed-effects model reported by using the in-
verse variance method [36].
Statistical heterogeneity of the effect estimates among
studies was assessed using I2 statistic which estimates
the percentage of total variation across studies that was
attributable to heterogeneity rather than to chance [37];
values greater than 50% were considered indicative of
high heterogeneity. We performed a meta-regression
analysis to explore the predictor effects of the supervised
exercise characteristics, such as length (weeks), fre-
quency (sessions per week), and duration (minutes per
session) on the effect estimates. Publication bias was
evaluated with the Egger’s test [36]. Two-sided P values
of less than 0.05 were considered statistically significant.
Results
Characteristics of the studies included
Nine studies [38-46] (n = 1156) were included in the sys-
tematic review and meta-analysis. The assessment of risk
of bias showed a mean PEDro score of 6.33 (SD = 1.1), in-
dicating consistent methodological quality and a low risk
of most biases (Table 1). The mean publication year for
the included studies was 2008 (SD = 4.5), and most were
conducted in North America (k = 3), United Kingdom,
Finland, Australia and Turkey. Figure 1 presents the
PRISMA flow diagram.
Characteristics of breast cancer survivors
The mean age of participants in the included studies
ranged from 48 to 60 years with an average of 55.2 years
old (SD = 4.1). Breast cancer survivors were predomin-
ately non-Hispanic whites. Supervised exercise training
groups comprised a total of 556 breast cancer survivors,
and 460 women were allocated to control groups. Sixty-
seven percent (n = 6 studies) [38,40,42-45] of the studies
were conducted during active treatment, including
chemotherapy and radiotherapy regimens. Regarding
treatment descriptions, 638 participants received chemo-
therapy, and 510 received radiotherapy. The studies
rarely reported time since diagnosis. Table 2 summarizes
the characteristics of the studies included.
Characteristics of supervised exercise interventions
Aerobic training was prescribed in all trials (n = 9)
[38-46], six of which included resistance training
[38,39,41-43,46]. Stretching exercises were performed in
one study [42]. Supervised exercise interventions had a
mean length of 21.4 weeks (SD 15.8) with a mean dur-
ation of 44.3 minutes (SD 15.2) and an average of 2.5
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Figure 1 Flowdiagram for search strategy methods. Flowdiagram is performed according to PRISMA Statement.
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substantially among studies, ranging from 50% to 80%
maximal heart rate (Table 2).
Adverse effects
No major adverse effects were reported among studies.
Courneya et al. [40] reported five adverse events in the
exercise group (lymphedema, gynecologic complaints
and influenza), while two adverse events (foot fracture
and bronchitis) occurred in the control group. Cantarero
et al. [39] reported discomfort or low-intensity pain/stiff-
ness after an exercise session in 3 patients; however,
these patients completed the exercise program. Con-
versely, Ergun et al. [41] and Winster et al. [46] reported
no adverse effects, including lymphedema, with exercise
interventions.
Pooled effects estimates for outcome measures
Cancer-related fatigue (CRF)
Pooled analysis demonstrated that supervised aerobic ex-
ercise was statistically more effective than conventional
care in improving CRF among breast cancer survivors
(SMD= −0.51, 95%CI −0.81 to −0.21), with high statistical
heterogeneity (P = 0.001; I2 = 75%) (Figure 2). Regarding
subgroup analysis, the pooled SMD for supervised resist-
ance training was −0.41 (95%CI −0.76 to −0.05), indicating
a moderate reduction in fatigue from this mode of training
(Figure 3). The effect of stretching exercise on CRF levelswas addressed by only one study [42], preventing the
calculation of pooled effect estimates for this mode of
training.
Meta-regression: heterogeneity and dose–response
interaction
Our meta-regression analysis showed that publication
year (P < 0.0001) and the length (P = 0.02) (Figure 4),
duration (P < 0.0001), and frequency (P < 0.0001) of the
supervised exercise interventions were significantly asso-
ciated with reductions on fatigue levels. No significant
dose–response interaction was observed for training
intensity (P > 0.05).
Publication bias
Moderate evidence of publication bias was detected for
the effects of supervised exercise interventions on CRF
by the Egger’s test (P = 0.04).
Effects of supervised exercise on CRF based on cancer
treatment stage
Five studies [38,40,42,43,45] evaluated the effects of super-
vised exercise on CRF in breast cancer receiving active
anti-cancer treatment (i.e., chemotherapy, radiotherapy,
hormone therapy or combination). The subgroup analysis
showed significant benefits from supervised exercise during
active treatment (SMD= −0.66, 95%CI −1.08 to −0.23),
high statistical heterogeneity was detected (P = 0.002; I2 =
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N = 22 Length = 12 weeks.
Female = 22 Duration = 20 min/session
Exp (n = 12) Frequency = 2 session/week
Age (yr) = 48 (10) Intensity = 60%-75%





Characteristics of cancer treatment =
Chemotherapy radiotherapy and
combination.
Exp = Aerobic exercise and resistance
training
PFS, The Spanish version
of the Profile of
Length = 8 weeks
N = 61 Duration = 60 min/session Mood States, The
“multiple sit-to-stand
test”, The trunk curl
static endurance test
Female = 61 Frequency = 3 session/week
Exp (n = 32) Intensity = 60%-75%
Age (yr) = 49 (7) Con = Conventional care
Con (n = 29)
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N = 52 Length = 15 weeks
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Exp (n = 24) Frequency = 3 session/week
Age (yr) = 59 (5) Intensity = 70%-75%
Con (n = 28) Con = Conventional care





Characteristics of cancer treatment =
Chemotherapy, radiotherapy,
mastectomy, axillary dissection and
sentinel lymph node biopsy
Exp = Aerobic exercise and resistance
training.
EORTC QLQ-C30, BFI,
BDI, ELISA kit, RayBio
Human
N = 60 Length = 12 weeks
Female = 60 Duration = 45 min/session Cytokine Antibody
Array 3
Exp (n = 20) Frequency = 3 session/week
Age (yr) = 49.65 (8.25) Intensity = 60%-80%
Home-based exercise (n = 20) Con = Home-based exercise (brisk
walking for 30 min/day for 3 days/
week) + education programme
Age (yr) = 55.05 (6.85) Education group = patient
information booklet that also
included lymphedema-specific
exercises
Education group (n = 20)





Characteristics of cancer treatment =
Chemotherapy – Radiotherapy




N = 58 Length = 12 weeks.
Female = 58 Duration = 30 min/ses.
Exp (n = 29) Frequency = 3 ses/wk.
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Table 2 Characteristics of the studies included (Continued)
Age (yr) = 55.2 (8.4) Intensity = about 75%.
Con (n = 29) Con = Delayed exercise group
Age (yr) = 55.1 (8.0) (DEG) completed the exercise
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Chemotherapy – Radiotherapy and
combination





12 minute walk test
N = 174 Length = 12 weeks.
Female = 174 Duration = 45 min/ses.
Exp (n = 82) Frequency = 2 ses/wk.
Age (yr) = 51.3 (10.3) Intensity = 50%-75%.
Con (n = 92) Con = Conventional care.





Characteristics of cancer treatment =
Chemotherapy – Radiotherapy
Exp = Aerobic exercise EORTC QLQ-C30,
FACIT-F, RBDI, WHQ
N = 500 Length = 48 weeks.
Female = 500 Duration = 60 min/ses.
Exp (n = 263) Frequency = 1 ses/wk.
Age (yr) = 52.3 (36–68) Intensity = 86%-92%.
Con (n = 237) Con = Encourage to maintain their
previous level of physical activity and





Characteristics of cancer treatment =
Chemotherapy
Exp = Aerobic exercise FACT-G, FACT-B, MOS
SF-36
N = 123 Length = 26 weeks.
Female = 123 Duration = No reported.
Exp (n = 42) Frequency = 3 ses/wk.
Age (yr) = 51.4 (8.7) Intensity = 50%-60%.
Con (n = 41) Con = Conventional care.
Age (yr) = 50.3 (8.7) Self-Directed Exercise Group = 5 times
per week progressive walking at 50%
to 60% maximal predicted oxygen
uptake.
Self-Directed Exercise
Group (n = 40)





Characteristics of cancer treatment =
Chemotherapy – Radiotherapy
Exp = Resistance training SCFS, 1-RM, PPB, Hand
grip dynamometry
N = 106 Length = 1 year.
Female = 106 Duration = 60 min/ses.
Exp (n = 52) Frequency = 2 ses/wk.
Age (yr) = 62.3 (6.7) Intensity = 60%-80%.
Con (n = 54) Con = Stretching placebo program.
Age (yr) = 62.6 (6.7)
Beck Depression Inventory, BDI; The Brief Fatigue Inventory, BFI; DXA (Dual-energy X-ray Absorptiometry); European Organization for Research and Treatment of
Cancer Quality of Life Questionnaire, EORTC QLQ-C30; Finnish modified version of Beck’s 13-item depression scale, RBDI; Functional Assessment of Cancer Therapy,
FACT – Breast (FACT-B), Fatigue (FACT-F), General (FACT-G); Functional Assessment of Chronic Illness Therapy (FACIT) questionnaire for fatigue (FACIT-F); Medical
Outcomes Study Short Form, MOS SF-36; Multidimensional Fatigue Inventory, MFSI-SF; Physical Activity Readiness Questionnaire, PARQ; Physical Performance
Battery, PPB; Piper Fatigue Scale, PFS; Positive And Negative Affect Scale, PANAS; Scottish Physical Activity Questionnaire, SPAQ; Schwartz Cancer Fatigue Scale,
SCFS; Satisfaction with Life Scale, SWLS; Women’s Health Questionnaire, WHQ.
*Age presented with mean and SD or range where reported.
**Supervised physical activity interventions usually consisted of a warm-up period, aerobic training (walking, cycling-ergometers and circuits), muscle strength
training (chest and leg curls), stretching exercises and a cool-down and relaxation period.
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Figure 2 Metaanalysis for the effect estimate of supervised exercise on CRF in Breast cancer survivors. Standardized mean difference
(SMD) was calculated for the Random effects model of metaanalysis. IV, inverse of variance; CI, confidence interval.
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breast cancer survivors after anti-cancer treatment
[39,41,44,46]. The pooled effect was not statistically
(SMD = −0.25, 95%CI −0.55 to 0.05) with high statis-
tical heterogeneity (P = 0.10; I2 = 76%) (Figure 5). Time
since diagnosis was not consistently reported by
authors, although most of the studies recruited women
who were beyond five years since primary cancer diagno-
sis. Hormone therapy included Tamoxifen and aromatase
inhibitors. See Table 3 for further details.Results for secondary outcome measures
As shown in Table 3, supervised exercise interventions
significantly improved functional and physical wellbeing,
but no significant effects were observed for social and
emotional well-being domains. There were no significant
differences between the supervised exercise group and
the control group in depression, BMI and physical activ-
ity level (P > 0.05).Figure 3 Metaanalysis for the effect estimate of supervised resistance
difference was (SMD) calculated for the Random effects model of metaanaDiscussion
Our meta-analysis revealed that supervised exercise has
a favorable effect on cancer-related fatigue when com-
pared with conventional care and it can be considered
as a safe therapy for the management of fatigue and
other domains of quality of life in breast cancer survi-
vors. These findings are in accordance with those re-
cently reported by Velthuis et al. [20] and Cramp et al.
[17], who found that exercise improved the psycho-
social and physical outcomes in cancer survivors during
and after treatment. Buffart et al. [47] recently stated
that it is necessary to continue studying the guidelines
for exercise prescription for cancer patients, specifically
regarding the type, localization and side effects related
to treatment.
In our subgroup analysis, resistance training significantly
improved CRF (SMD= −0.55; 95%CI, −1.09 to −0.01).
Similar results have been published in the literature. Milne
et al. [42] reported that resistance training produced im-
portant benefits on CRF and muscular strength in breasttraining on CRF in Breast cancer survivors. Standardized mean
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Figure 4 Bubble plot for the dose–response relationship between the intervention length (weeks) and effect estimates changes for
CRF from the nine randomized controlled trials included in the meta-regression analysis (P = 0.02).
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were confirmed by Yuen and Sword in 2007 [48]. In a re-
cent meta-analysis, Strasser et al. [49] found that resist-
ance training during active treatment produced important
gains in muscular strength and body composition. Muscu-
lar strength was not evaluated in our study due to theFigure 5 Metaanalysis for the effect estimate of supervised resistan
anti-cancer treatment stage. Standardized mean difference was (SMD)
of variance; CI, confidence interval.large differences in the reports obtained from the studies
included. Only one study examined the effects of stretch-
ing exercise programs and found it to be beneficial [42].
It has been reported that supervision plays an import-
ant role in the benefits of exercise among breast cancer
survivors [20]. The mechanism underlying the benefit ofce training on CRF in Breast cancer survivors according to the
calculated for the Random effects model of metaanalysis. IV, inverse
Table 3 Effect size estimates for comparisons and secondary outcomes included in the meta-analysis
Outcome Effect size random effects model –SMD* (95%CI) Statistical heterogeneity (I2)
Primary outcome (CRF)
Supervised aerobic exercise −0.51, 95%CI [−0.81, −021], (P = 0.001) † 75%
Supervised resistance training −0.41, 95%CI [−0.76, −0.05], (P = 0.02) † 64%
Supervised exercise during active anti-cancer treatment −0.66, 95%CI [−1.08, −0.23], (P = 0.002) † 78.6%
Supervised exercise after anti-cancer treatment −0.25, 95%CI [−0.55, 0.05], (P = 0.10) 85.8%
Secondary outcomes
Depression −0.23, 95%CI [−0.55, 0.09], (P = 0.16) 69%
Body mass index −0.14, 95%CI [−0.38, 0.11], (P = 0.28) 0%
Physical activity level 1.10, 95%CI [−0.41, 2.62], (P = 0.15) 85%
Health-related quality of life
Physical wellbeing 0.63, 95%CI [0.08, 1.18], (P = 0.02) † 89%
Functional wellbeing 0.60, 95%CI [0.08, 1.11], (P = 0.02) † 89%
Social wellbeing 0.08, 95%CI [−0.11, 0.27], (P = 0.24) 28%
Emotional wellbeing 0.30, 95%CI [−0.05, 0.65], (P = 0.09) 76%
*Standarized mean difference.
† Significant differences observed (P < 0.05).
Cancer-related fatigue, CRF.
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ence and intensity, perhaps because of greater encourage-
ment or confidence when the help of a health professional
is available. In 2009, Whitehead and Lavelle [50] reported
that breast cancer survivors preferred supervised exercise
training compared to unsupervised exercise. Recently,
Markes et al. [51] compared supervised and non-supervised
exercise in breast cancer survivors and reported non-
significant differences between groups, although the au-
thors reported significant improvements in fitness and daily
activities. In light of this, our results demonstrate a favor-
able tendency in favor of supervised interventions, although
our recommendations need to be confirmed by larger
randomized controlled trials.
When examining statistical heterogeneity, we found
significant positive impacts on CRF with increasing length,
duration and frequency of the supervised exercise inter-
ventions. Meta-regression analysis showed than exercise
interventions performed for more than 28 weeks, nearly 3
sessions per week and lasting 40 minutes per session exert
larger effects that low-volume exercise interventions.
These dose–response relationships are in agreement with
two recent meta-analyses published by Brown et al. [11]
and Strasser et al. [14]. On the contrary, we observed no
statistically significant dose–response relationship between
high intensity (>80% maximal heart rate) of supervised ex-
ercise and CRF in breast cancer survivors, even though a
strong body of research from previous meta-analyses have
demonstrated that high-intensity aerobic and resistance
training can provide larger effects than aerobic exercise
alone on CRF [11,14,17,20]. Hence, further research is
needed to elucidate the role of supervised exerciseintensity and the optimal dose of exercise in the manage-
ment of CRF in women with breast cancer.
An additional relevant finding related to this meta-
analysis is that we observed significant benefits on sev-
eral domains of quality of life (physical and functional
well-being) in breast cancer survivors following super-
vised exercise (see Table 3). These results are consistent
with those recently reported by Mishra et al. [52] in a
recent Cochrane review concerning exercise and quality
of life in cancer survivors. The authors concluded that
exercise improves some health-related quality of life
domains, such as functional well-being, cancer-specific
concerns (e.g., breast cancer), anxiety, fatigue, and other
outcomes. Interestingly, the authors encouraged further
research to investigate the effects of different training
modalities. On the other hand, no evidence of any effect
was observed for depression (P = 0.16), body mass index
(P = 0.28) and physical activity level (P = 0.15). This lack
of significance could be explained by the small number
of studies that reported effect estimates for these out-
comes and the evident clinical heterogeneity in their
measurement. Conversely, other studies have reported
consistent changes in depression after exercise interven-
tions in cancer survivors [53].
Our study has several limitations. Emerging evidence
has suggested that physical exercise can improve sys-
temic inflammation in cancer survivors [54-57], and it is
widely known that cytokines and inflammatory markers
are associated with CRF levels [58], though not all stud-
ies agree [59-61]. Additionally, it was not possible to
evaluate the changes on inflammatory markers following
supervised exercise, since only Ergun et al. [41] reported
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trials are required to achieve consensus on this topic.
The statistical heterogeneity of our results can be attrib-
uted to the variability in reporting of several outcome
measures (i.e., fatigue, depression, data for quality of life,
etc.), intervention procedures and tools used. This report-
ing heterogeneity and the low availability of data from the
studies prevented the analysis of other outcomes, such as
muscular strength, and blood biomarkers, including
inflammatory cytokines, leptin, glucose-related markers
and other tumoral markers. The observed heterogeneity in
reporting procedures leads us to recommend that further
clinical trials be conducted in a more uniform way in
order to achieve strong consensus about the effects of
exercise training for breast cancer survivors.Conclusions
In summary, our findings demonstrate that supervised ex-
ercise could be considered a safe and effective intervention
in improving cancer-related fatigue among breast cancer
survivors. On the basis of our results, we recommend that
supervised and structured exercise programs be prescribed
to breast cancer survivors, regardless of treatment stage as
a means to improve cancer-related fatigue and some do-
mains of overall quality of life. Further research is required
to strengthen this evidence.Annexes
Appendix 1. Search strategy details
1. randomized controlled trial [Publication Type]
2. controlled clinical trial [Publication Type]
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7. Breast cancer [Title/Abstract]
8. (tumour* or tumor*) [Title/Abstract]
9. carcino* [Title/Abstract]
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